Emerging Market Equities Underestimating Tariff Impact, UBS Warns

Analysts at UBS have issued a cautionary statement regarding the outlook for emerging market equities, suggesting that current valuations may not adequately reflect the escalating risks posed by increasing U.S. tariffs. Given the substantial reliance of many emerging economies on exports, particularly to the United States, any further tightening of trade restrictions could significantly impact corporate earnings and, consequently, stock market performance. This assessment highlights a potential disconnect between market pricing and the underlying economic realities of a deepening global trade conflict, urging investors to reconsider their exposure to these volatile assets.

The analysis from UBS underscores a critical vulnerability for emerging market economies: their significant dependence on international trade. Specifically, the report notes that more than 35% of the revenues generated by companies within the MSCI Emerging Markets Index are derived from exports. A considerable portion of this, approximately 13%, is directly tied to trade with the United States. This intricate web of global supply chains means that any disruption, such as heightened tariff barriers, can have a magnified effect on these economies.

UBS’s research indicates that the average U.S. tariff rate, currently standing at 16%, could potentially surge to 21% if previously implemented tariff levels are fully reinstated. This dramatic increase from a mere 2.4% in 2024 signifies a considerable burden for exporting nations. Such a scenario would inevitably lead to higher costs for goods, reduced demand, and a squeeze on profit margins for companies operating in these markets. The direct consequence would be a downward revision of earnings forecasts, which, according to UBS’s stress tests, could see a 6% to 9% reduction in emerging market earnings. In contrast, recent market adjustments have only seen a modest 3% trimming of earnings expectations, indicating a significant underestimation of the potential impact.

This discrepancy between projected and actual earnings adjustments suggests that the market has not yet fully internalized the severity of potential trade disputes. As these economic realities become clearer and more downgrades in earnings forecasts materialize, UBS anticipates a negative impact on the performance of emerging market equities. The ripple effects of prolonged trade tensions and an ensuing economic deceleration are likely to put additional pressure on these markets, making a compelling case for investors to exercise caution and re-evaluate their positions.

In summary, the latest insights from UBS underscore a critical, unaddressed risk within emerging market equity valuations. The significant reliance of these economies on export revenues, particularly from the U.S., exposes them to considerable peril from rising tariffs. Should trade protectionism intensify, the existing market forecasts for earnings may prove overly optimistic, setting the stage for potential underperformance in emerging market stocks.